世界の低侵襲白内障手術装置市場 – 業界動向と2030年までの予測

Request for TOC TOC のリクエスト Speak to Analyst アナリストに相談する Buy Now今すぐ購入 Inquire Before Buying 事前に問い合わせる Free Sample Report 無料サンプルレポート

世界の低侵襲白内障手術装置市場 – 業界動向と2030年までの予測

  • Medical Devices
  • Upcoming Report
  • Nov 2022
  • Global
  • 350 ページ
  • テーブル数: 220
  • 図の数: 60

世界の低侵襲白内障手術装置市場

Market Size in USD Billion

CAGR :  % Diagram

Diagram 予測期間
2023 –2030
Diagram 市場規模(基準年)
USD 5.50 Billion
Diagram Market Size (Forecast Year)
USD 44.87 Billion
Diagram CAGR
%
Diagram Major Markets Players
  • Hoya Corporation
  • AbbVie
  • Essilor
  • NIDEK Co.
  • Lumenis Be

世界の低侵襲白内障手術装置市場、製品タイプ別(インプラントとステント、緑内障ドレナージ、緑内障レーザー装置、眼内レンズ、眼科粘弾性装置、水晶体乳化吸引システム)、手術タイプ別(白内障合併緑内障、フェムト秒レーザー手術、水晶体乳化吸引、白内障嚢外摘出手術、単独緑内障)、エンドユーザー別(病院、外来手術センター、眼科クリニック、その他)– 2030年までの業界動向と予測。

低侵襲白内障手術装置市場

 低侵襲白内障手術機器市場分析と規模

2021年9月に発表された米国疾病管理予防センターの最新報告書によると、心臓病は米国における主な死因です。20歳以上の成人約1,820万人が冠動脈疾患を患っており、2019年には約360,900人がこの疾患で亡くなりました。心血管疾患による死亡率が高いため、手術件数は増加すると予想されます。低侵襲手術の人気が高まるにつれ、対象市場は予測期間中に拡大すると予想されます。がんも米国で最も一般的な慢性疾患の1つであり、今後数年間で市場の成長を牽引するでしょう。

Data Bridge Market Research の分析によると、2022 年に 55 億米ドルだった低侵襲白内障手術装置市場は、2023 年から 2030 年の予測期間中に 30% の CAGR で成長し、2030 年には 448.7 億米ドルに達すると予想されています。市場価値、成長率、セグメンテーション、地理的範囲、主要プレーヤーなどの市場シナリオに関する洞察に加えて、Data Bridge Market Research がまとめた市場レポートには、詳細な専門家の分析、患者の疫学、パイプライン分析、価格分析、規制の枠組みも含まれています。

低侵襲白内障手術機器市場の範囲とセグメンテーション      

レポートメトリック

詳細

予測期間

2023年から2030年

基準年

2022

歴史的な年

2021 (2015 - 2020 にカスタマイズ可能)

定量単位

売上高(10億米ドル)、販売数量(個数)、価格(米ドル)

対象セグメント

製品タイプ(インプラントおよびステント、緑内障ドレナージ、緑内障レーザー装置、眼内レンズ、眼科用粘弾性装置、超音波乳化吸引システム)、手術タイプ(白内障合併緑内障、フェムト秒レーザー手術、超音波乳化吸引術、白内障嚢外摘出手術、単独緑内障)、エンドユーザー(病院、外来手術センター、眼科クリニック、その他)

対象国

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Hoya Corporation (Japan), AbbVie Inc. (U.K.), Essilor (France), NIDEK Co., Ltd. (U.S.), Lumenis Be Ltd. (Israel), Abbott (U.S.), Johnson & Johnson Services Inc. (U.S.), New World Medical Inc. (U.S.), Carl Zeiss Meditech AG (Germany), Alcon Vision LLC. (Switzerland), Opcon USA (U.S.), Bausch & Lomb, Incorporated (U.S.), and STAAR SURGICAL (U.S.)

Market Opportunities

  • Higher acceptance rate of minimally invasive surgeries over traditional surgeries
  • Increasing prevalence of lifestyle-related and chronic disorders

Market Definition

Minimally invasive surgery employs surgical techniques that use small tools, cameras, and lights to limit the size and number of cuts or incisions made during an operation. This procedure is much safer than traditional open surgery because it results in fewer complications, faster recovery, less blood loss, better results, and shorter hospital stays. These surgeries are gaining popularity among surgeons and patients worldwide because of these factors. They are mostly used in cardiothoracic, orthopaedic, vascular, and neurological surgeries. Compared to conventional glaucoma surgery devices, minimally invasive surgery (MIGS) devices provide a safer and less invasive method of reducing intraocular pressure (IOP).

Global Minimally Invasive Cataract Surgery Devices Market Dynamics

Drivers

  • Growing acceptance of minimally invasive surgeries than traditional surgeries

MIS procedures have several advantages over traditional procedures, including less post-operative pain, faster recovery times, less stress on the immune system, fewer major operative and post-operative complications, less scarring and smaller incisions. MIS procedures are becoming more popular worldwide because the benefits of minimally invasive procedures reduce overall hospital and treatment costs, driving the market growth.

  • Rising prevalence of chronic diseases

The rising prevalence of chronic diseases such as cancer and cardiovascular disease is increasing demand for surgical procedures for treatment, boosting market growth. According to the World Health Organization's (WHO) 2021 fact sheet, noncommunicable diseases (NCDs), also known as chronic diseases, kill approximately 41 million people each year, accounting for approximately 71% of all deaths worldwide. According to the same source, over 15 million people aged 30-69 die worldwide each year as a result of NCDs. As a result of the high mortality rate from NCDs, the demand for treatment procedures is increasing.

As minimally invasive procedures have more advantages over traditional procedures, they are gaining traction. Thus, the studied market is grow during the forecast period.

Opportunities

  • New product launch

Collaborations, mergers, and acquisitions are important strategic actions carried out by industry participants that are anticipated to have a favourable impact on the market. New product launches as a result of technical breakthroughs. The market is anticipated to expand steadily throughout the projected period as a result of the creation of novel solutions. A good example is the ELUXEO surgical system, which was introduced by Fujifilm Medical Systems USA Inc. in July 2020. It combines the company's endoscopy and minimally invasive surgery portfolios and enables surgeons to perform both flexible and rigid endoscopy from a single tower by improving visualisation.

Restraints/Challenges

  • Shortage of Experienced Professionals

As opposed to open surgery, minimally invasive procedures are carried out by surgical specialists using advanced medical technology. These treatments must be performed by experienced professionals. Surgical specialists are the primary users of minimally invasive surgery equipment, and many countries suffer from a global shortage of skilled medical personnel. Because of this scarcity, patients who prefer a minimally invasive procedure must reluctantly undergo conventional procedures.

This scarcity is especially acute in rural areas, where the government owns the majority of healthcare facilities. The government is heavily funding various programmes to improve the state of health in rural areas.

This minimally invasive cataract surgery devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the minimally invasive cataract surgery devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on the Minimally Invasive Cataract Surgery Devices Market

The COVID-19 pandemic has had an impact on a variety of surgical procedures, including minimally invasive. Due to the lockdown restrictions, patients with various lifestyle-related and chronic diseases experienced a delay in diagnosis and treatment as a result of fewer hospital visits, which impacted the studied market. As a result of the current pandemic scenario, this data indicates that minimally invasive surgical procedures have declined, which will affect the procurement of minimally invasive surgical procedures and devices, thereby affecting the market. However, with ongoing vaccinations and decreasing COVID-19 cases, the studied market is expected to recover to its full potential during the forecast period of the study.

Recent Developments

  • In April 2021, in collaboration with Veran Medical Technologies Inc., Olympus Corporation launched the 510(k)-cleared H-SteriScope Single-Use Bronchoscopes, a line of five premium endoscopes for use in advanced diagnostic and therapeutic procedures.
  • In May 2021, The NaviCamTM Magnetically Controlled Capsule Endoscopy (MCCE) system received premarketing approval from the Food and Drug Administration. As a result, the aforementioned factors are expected to drive the region's minimally invasive surgery devices market growth.

Global Minimally Invasive Cataract Surgery Devices Market Scope

The minimally invasive cataract surgery devices market is segmented on the basis of product type, surgery type and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

  • Implant and Stent
  • Glaucoma Drainage
  • Glaucoma Laser Device
  • Intraocular Lens
  • Opthalmic Viscoelastic Device
  • Phacoemulsification System

 Surgery Type

  • Glaucoma in Conjunction with Cataract
  • Femtosecond Laser Surgery
  • Phacoemulsification
  • Extracapsular Cataract Extraction Surgery
  • Stand Alone Glaucoma

  End-User

  • Hospitals
  • Outpatient Surgery Center
  • Ophthamology Clinic
  • Others

Minimally Invasive Cataract Surgery Devices Market Regional Analysis/Insights

The minimally invasive cataract surgery devices market is analyzed and market size insights and trends are provided by country, product type, surgery type and end-user as referenced above.

The countries covered in the minimally invasive cataract surgery devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the minimally invasive cataract surgery devices market because of the increasing prevalence of cataract patients, the growing geriatric population, and growing public awareness of the benefits of cataract surgery.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 owing to the increase in surgical procedures, an aging population, and a high burden of chronic diseases.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The minimally invasive cataract surgery devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for minimally invasive cataract surgery devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the minimally invasive cataract surgery devices market. The data is available for historic period 2011-2021.

Competitive Landscape and Minimally Invasive Cataract Surgery Devices Market Share Analysis

低侵襲白内障手術装置市場の競争状況は、競合他社ごとに詳細を提供します。詳細には、会社概要、会社の財務状況、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、世界的なプレゼンス、生産拠点と施設、生産能力、会社の強みと弱み、製品の発売、製品の幅と広さ、アプリケーションの優位性が含まれます。提供されている上記のデータ ポイントは、低侵襲白内障手術装置市場に関連する会社の焦点にのみ関連しています。

低侵襲白内障手術装置市場で活動している主要企業は次のとおりです。

  • HOYA株式会社(日本)
  • アッヴィ社(英国)
  • エシロール(フランス)
  • ニデック株式会社(米国)
  • ルメニス・ビー・リミテッド(イスラエル)
  • アボット(米国)
  • ジョンソン・エンド・ジョンソン・サービス社(米国)
  • ニューワールドメディカル株式会社(米国)
  • カールツァイスメディテックAG(ドイツ)
  • アルコンビジョンLLC(スイス)
  • オプコンUSA(米国)
  • ボシュロム社(米国)
  • スターサージカル(米国)


SKU-

世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする

  • インタラクティブなデータ分析ダッシュボード
  • 成長の可能性が高い機会のための企業分析ダッシュボード
  • カスタマイズとクエリのためのリサーチアナリストアクセス
  • インタラクティブなダッシュボードによる競合分析
  • 最新ニュース、更新情報、トレンド分析
  • 包括的な競合追跡のためのベンチマーク分析のパワーを活用
デモのリクエスト

調査方法

データ収集と基準年分析は、大規模なサンプル サイズのデータ​​収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。

DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。

カスタマイズ可能

Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。

Frequently Asked Questions

The market is segmented based on , By Product Type (Implant and Stent, Glaucoma Drainage, Glaucoma Laser Device, Intraocular Lens, Opthalmic Viscoelastic Device, Phacoemulsification System), Surgery Type (Glaucoma in Conjunction with Cataract, Femtosecond Laser Surgery, Phacoemulsification, Extracapsular Cataract Extraction Surgery, Stand Alone Glaucoma), End-User (Hospitals, Outpatient Surgery Center, Ophthamology Clinic, Others) – Industry Trends and Forecast to 2030. .
The Global Minimally Invasive Cataract Surgery Devices Market size was valued at USD 5.50 USD Billion in 2022.
The Global Minimally Invasive Cataract Surgery Devices Market is projected to grow at a CAGR of 30% during the forecast period of 2023 to 2030.
The major players operating in the market include Hoya Corporation, AbbVie , Essilor, NIDEK Co. , Lumenis Be , Abbott, Johnson & Johnson Services , New World Medical , Carl Zeiss Meditech AG, Alcon Vision LLC., Opcon USA, Bausch & Lomb orporated, STAAR SURGICAL.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.